AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33639516 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 48
Study 32392700 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Number of subjects: 120
Study 32392700 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 120
Study 32392700 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study 36402794 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral nail anti-rotation (PFNA) fixation
Number of subjects: 450
Study 36402794 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Scoring System (ISSI)
Number of subjects: 450
Study 36352475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five complementary strategies: feedback and transparency
Number of subjects: 26
Study 36352475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five complementary strategies: intervention sustainability
Number of subjects: 26
Study 36352475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five complementary strategies: clinical practice guideline adherence
Number of subjects: 26
Study 36352475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five complementary strategies: productive partnerships
Number of subjects: 26
Study 36352475 — intervention group
Group type: EXPERIMENTAL
Intervention: Five complementary strategies: whole-of-team approach
Number of subjects: 26
Study 32711519 — intervention group
Group type: EXPERIMENTAL
Intervention: Avenanthramide (AVA) supplementation (206 mg/kg)
Number of subjects: 24
Study 32711519 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg/kg)
Number of subjects: 24
Study 35722469 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/Esketamine
Number of subjects: 238
Study 35722469 — intervention group
Group type: COMPARATOR
Intervention: Propofol/Fentanyl
Number of subjects: 238
Study 32497714 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure applied on SP6, SP10, ST36, and LI11 points
Number of subjects: 90
Study 32497714 — intervention group
Group type: COMPARATOR
Intervention: Sham control (ineffective points)
Number of subjects: 90
Study 32497714 — intervention group
Group type: COMPARATOR
Intervention: Negative control (routine care)
Number of subjects: 90
Study 35232402 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 45
Study 35232402 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 45
Study 35232402 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 45
Study 32369446 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant metformin, debulking surgery, and adjuvant chemotherapy plus metformin
Number of subjects: 38
Study 32369446 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy and metformin, interval debulking surgery, and adjuvant chemotherapy plus metformin
Number of subjects: 38
Study 35443107 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (eating only between 8:00 a.m. and 4:00 p.m.) with calorie restriction
Number of subjects: 139
Study 35443107 — intervention group
Group type: COMPARATOR
Intervention: Daily calorie restriction alone
Number of subjects: 139
Study 35443107 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating
Number of subjects: 139
Study 35443107 — intervention group
Group type: COMPARATOR
Intervention: Time-restricted eating and daily calorie restriction
Number of subjects: 139
Study 34140351 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal music listening
Number of subjects: 38
Study 34140351 — intervention group
Group type: COMPARATOR
Intervention: Audiobooks
Number of subjects: 38
Study 36192769 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Support for Health Action (FAM-ACT)
Number of subjects: 268
Study 36192769 — intervention group
Group type: COMPARATOR
Intervention: Individual patient-focused DSMES (I-DSMES)
Number of subjects: 268
Study 36192769 — intervention group
Group type: EXPERIMENTAL
Intervention: FAM-ACT
Number of subjects: 268
Study 34820354 — intervention group
Group type: EXPERIMENTAL
Intervention: Brochure group
Number of subjects: 155
Study 34820354 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram group
Number of subjects: 155
Study 34820354 — intervention group
Group type: EXPERIMENTAL
Intervention: Online interactive educational workshop group
Number of subjects: 155
Study 34820354 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo intervention)
Number of subjects: 155
Study 32729887 — intervention group
Group type: EXPERIMENTAL
Intervention: Mx protocol (annual mammography and clinical breast examination)
Number of subjects: 10000000
Study 32729887 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI protocol (annual MRI and clinical breast examination plus biennial mammography)
Number of subjects: 10000000
Study 32729887 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging every 18 months between ages 35 and 60 years
Number of subjects: 10000000
Study 32729887 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual screening alternating MRI and mammography between ages 35 and 60 years
Number of subjects: 10000000
Study 33436106 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC) - 6 sessions at -130°C over 6 weeks
Number of subjects: 23
Study 34883524 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard medical care + telemonitoring device
Number of subjects: 60
Study 34883524 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 60
Study 34883524 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetry use
Number of subjects: 60
Study 34883524 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary heart disease presence
Number of subjects: 60
Study 34883524 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension presence
Number of subjects: 60
Study 34883524 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient's body mass
Number of subjects: 60
Study 36229973 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety guidewire (SGW)
Number of subjects: 348
Study 36229973 — intervention group
Group type: COMPARATOR
Intervention: No safety guidewire (NSGW)
Number of subjects: 348
Study 32868858 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose-free infant formula (Similac Sensitive®)
Number of subjects: 74
Study 32868858 — intervention group
Group type: COMPARATOR
Intervention: Lactose-containing infant formula (Similac Advance®)
Number of subjects: 74
Study 32502923 — intervention group
Group type: EXPERIMENTAL
Intervention: SB8
Number of subjects: 763
Study 34667103 — intervention group
Group type: EXPERIMENTAL
Intervention: DSP with memory aids
Number of subjects: 469
Study 34667103 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus existing dementia guide
Number of subjects: 469
Study 33677430 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support approach (3 groups, n = 51)
Number of subjects: 103
Study 33677430 — intervention group
Group type: COMPARATOR
Intervention: Control group (3 groups, n = 52)
Number of subjects: 103
Study 36193841 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 214
Study 36193841 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 214
Study 32569414 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel neurotomy
Number of subjects: 43
Study 32569414 — intervention group
Group type: COMPARATOR
Intervention: Perpendicular neurotomy
Number of subjects: 43
Study 36099211 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase + Methotrexate (MTX)
Number of subjects: 152
Study 36099211 — intervention group
Group type: COMPARATOR
Intervention: Pegloticase + Placebo (PBO)
Number of subjects: 152
Study 34487875 — intervention group
Group type: COMPARATOR
Intervention: Conventional Etch and Rinse + MC (Control)
Number of subjects: 60
Study 34487875 — intervention group
Group type: EXPERIMENTAL
Intervention: CP + BA
Number of subjects: 60
Study 34487875 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP + BA
Number of subjects: 60
Study 34487875 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP + MC
Number of subjects: 60
Study 34487875 — intervention group
Group type: EXPERIMENTAL
Intervention: CP + MC
Number of subjects: 60
Study 34487875 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 35412472 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Mobilization + Neuromuscular Electrical Stimulation (EM+NMES)
Number of subjects: 139
Study 35412472 — intervention group
Group type: COMPARATOR
Intervention: Early Mobilization (EM)
Number of subjects: 139
Study 33091332 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for predicting overall survival (OS)
Number of subjects: 1822
Study 33091332 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 1822
Study 32326082 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 94
Study 32326082 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise (PE)
Number of subjects: 94
Study 32326082 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 94
Study 34789618 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 28
Study 34789618 — intervention group
Group type: COMPARATOR
Intervention: Mepivacaine
Number of subjects: 28
Study 34755014 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy (LAP)
Number of subjects: 1028
Study 34755014 — intervention group
Group type: COMPARATOR
Intervention: Open colectomy (OP)
Number of subjects: 1028
Study 35477351 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonlicromanol
Number of subjects: 24
Study 35477351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33464392 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA therapy (methotrexate 7.5 mg/week, sulfasalazine 2 g/day plus initially prednisolone 60 mg/day)
Number of subjects: 155
Study 33464392 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA-light therapy (methotrexate 25 mg/week plus initially prednisolone 30 mg/day)
Number of subjects: 155
Study 33159283 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel applied on the mask edge
Number of subjects: 74
Study 33159283 — intervention group
Group type: COMPARATOR
Intervention: Standard mask ventilation without gel
Number of subjects: 74
Study 32611224 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Home‐Life Intervention
Number of subjects: 113
Study 33876666 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower social support
Number of subjects: 4507
Study 33876666 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower scores on social autonomy
Number of subjects: 4507
Study 33876666 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased suicidality risk score
Number of subjects: 4507
Study 33876666 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower scores on psychosocial functioning
Number of subjects: 4507
Study 32199523 — intervention group
Group type: EXPERIMENTAL
Intervention: HPD alone (1.5 to 2.2 g/kg/day protein)
Number of subjects: 26
Study 32199523 — intervention group
Group type: EXPERIMENTAL
Intervention: HPD plus multistrain probiotic formulation
Number of subjects: 26
Study 32199523 — intervention group
Group type: EXPERIMENTAL
Intervention: HPD plus prebiotic (5.6 g inulin)
Number of subjects: 26
Study 32199523 — intervention group
Group type: EXPERIMENTAL
Intervention: HPD plus synbiotic (probiotic plus inulin)
Number of subjects: 26
Study 32199523 — intervention group
Group type: EXPERIMENTAL
Intervention: HPD (all variations)
Number of subjects: 26
Study 32199523 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 26
Study 36195460 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality shared toilets (users contributed 10%-15% of capital cost)
Number of subjects: 424
Study 36195460 — intervention group
Group type: COMPARATOR
Intervention: Low-quality pit latrines (control group)
Number of subjects: 424
Study 33932507 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin 1.5 mg/m2 every 3 weeks
Number of subjects: 103
Study 33932507 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 103
Study 32441407 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement-retained abutment (n = 24)
Number of subjects: 21
Study 32441407 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium base (n = 28)
Number of subjects: 21
Study 34052081 — intervention group
Group type: EXPERIMENTAL
Intervention: Popliteal-sciatic nerve block with 0.5% Bupivacaine (0.25 ml/kg) in Group 2A (ages 7–15)
Number of subjects: 40
Study 34052081 — intervention group
Group type: COMPARATOR
Intervention: Local surgical site infiltration with 0.5% Bupivacaine (0.25 ml/kg) in Group 2B (ages 7–15)
Number of subjects: 40
Study 34052081 — intervention group
Group type: EXPERIMENTAL
Intervention: Popliteal-sciatic nerve block with 0.5% Bupivacaine (0.25 ml/kg) in Group 1A (ages 1–6)
Number of subjects: 40
Study 34052081 — intervention group
Group type: COMPARATOR
Intervention: Local surgical site infiltration with 0.5% Bupivacaine (0.25 ml/kg) in Group 1B (ages 1–6)
Number of subjects: 40
Study 34052081 — intervention group
Group type: EXPERIMENTAL
Intervention: Popliteal-sciatic nerve block in Group 2A (ages 7–15)
Number of subjects: 40
Study 34052081 — intervention group
Group type: COMPARATOR
Intervention: Local surgical site infiltration in Group 2B (ages 7–15)
Number of subjects: 40
Study 32680875 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration thrombectomy
Number of subjects: 165
Study 32680875 — intervention group
Group type: COMPARATOR
Intervention: Stent retriever thrombectomy
Number of subjects: 165
Study 35039260 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate combined with rhEGF eye drops
Number of subjects: 97
Study 35039260 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops
Number of subjects: 97
Study 33739487 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional nursing management including continuous epitympanic temperature monitoring, early installation in a heated ambulance (temperature target >30°C), protection by a survival blanket, and use of heated solutes (temperature objective >35°C).
Number of subjects: 1200
Study 33739487 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (control group).
Number of subjects: 1200
Study 32969833 — intervention group
Group type: EXPERIMENTAL
Intervention: BBL‐GP (web‐based intervention augmented with an in‐person diet and physical activity consultation)
Number of subjects: 125
Study 32969833 — intervention group
Group type: EXPERIMENTAL
Intervention: LMP (single clinician‐led group, Lifestyle Modification Program)
Number of subjects: 125
Study 32969833 — intervention group
Group type: COMPARATOR
Intervention: Control (web‐based control)
Number of subjects: 125
Study 36026525 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous AG training (1×30 min/day)
Number of subjects: 24
Study 36026525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent AG training (6 × 5 min/day)
Number of subjects: 24
Study 36026525 — intervention group
Group type: COMPARATOR
Intervention: Control group (no AG training)
Number of subjects: 24
Study 33277091 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mcg/kg dexmedetomidine
Number of subjects: 0
Study 33277091 — intervention group
Group type: COMPARATOR
Intervention: 0.03 mg/kg midazolam
Number of subjects: 0
Study 33277091 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 36463433 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Peyton teaching approach (G1)
Number of subjects: 40
Study 36463433 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method (watching a teaching video for 30 min) (G2)
Number of subjects: 40
Study 36463433 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 32011723 — intervention group
Group type: EXPERIMENTAL
Intervention: Kerala Diabetes Prevention Program (K-DPP) intervention delivered by peer leaders over 12 months.
Number of subjects: 375000
Study 36006668 — intervention group
Group type: EXPERIMENTAL
Intervention: Headspace (unguided digital mindfulness-based self-help app)
Number of subjects: 2182
Study 36006668 — intervention group
Group type: EXPERIMENTAL
Intervention: Headspace
Number of subjects: 2182
Study 36006668 — intervention group
Group type: COMPARATOR
Intervention: Moodzone (active control)
Number of subjects: 2182
Study 34474011 — intervention group
Group type: EXPERIMENTAL
Intervention: ? blockers in sinus rhythm (n=12,822)
Number of subjects: 15659
Study 34474011 — intervention group
Group type: EXPERIMENTAL
Intervention: ? blockers in atrial fibrillation (n=2837)
Number of subjects: 15659
Study 34474011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15659
Study 32768331 — intervention group
Group type: EXPERIMENTAL
Intervention: Yang Yan Qing E Wan (YYQEW)
Number of subjects: 0
Study 32768331 — intervention group
Group type: COMPARATOR
Intervention: Model group (H2O2 treatment)
Number of subjects: 0
Study 35487141 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo with treatment rationale (OLP+)
Number of subjects: 45
Study 35487141 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo without treatment rationale (OLP-)
Number of subjects: 45
Study 35487141 — intervention group
Group type: COMPARATOR
Intervention: No pill control (NPC)
Number of subjects: 45
Study 33905555 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant docetaxel and androgen deprivation therapy
Number of subjects: 100
Study 33905555 — intervention group
Group type: COMPARATOR
Intervention: Control group (no neoadjuvant therapy)
Number of subjects: 100
Study 34428112 — intervention group
Group type: EXPERIMENTAL
Intervention: Liq HRV
Number of subjects: 451
Study 34428112 — intervention group
Group type: COMPARATOR
Intervention: Lyo HRV
Number of subjects: 451
Study 36350392 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Reality Ultrasound (AR US)
Number of subjects: 44
Study 36350392 — intervention group
Group type: COMPARATOR
Intervention: Standard Ultrasound (sUS)
Number of subjects: 44
Study 32877884 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 20
Study 32877884 — intervention group
Group type: COMPARATOR
Intervention: Conventional IFL (sharp/diathermia)
Number of subjects: 20
Study 32877884 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20
Study 36273179 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation scenarios with varying levels of interaction effects
Number of subjects: 3278
Study 36273179 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation scenarios with no 'true' intervention effect
Number of subjects: 3278
Study 36273179 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation scenarios with 'true' intervention effects
Number of subjects: 3278
Study 36273179 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size adjustments
Number of subjects: 3278
Study 33755674 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-90 brachytherapy (15-20Gy)
Number of subjects: 31
Study 33755674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone and 5-fluorouracil injections
Number of subjects: 31
Study 33755674 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjuvant treatment)
Number of subjects: 31
Study 35428979 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (>60 seconds or when the cord stopped pulsing)
Number of subjects: 122
Study 35428979 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (within 15 seconds after birth)
Number of subjects: 122
Study 35428979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study 32659482 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial random noise stimulation (tRNS) + DC-offset
Number of subjects: 49
Study 32659482 — intervention group
Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 49
Study 32659482 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 49
Study 34918332 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol treatment (150 mg/day)
Number of subjects: 8
Study 34918332 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8
Study 32942043 — intervention group
Group type: EXPERIMENTAL
Intervention: Zibotentan (10 mg daily)
Number of subjects: 0
Study 32942043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 37409840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1 µg kg ‐1 and midazolam 0.12 mg kg ‐1 (DM group)
Number of subjects: 150
Study 37409840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1 µg kg ‐1 and ketamine 2 mg kg ‐1 (DK group)
Number of subjects: 150
Study 37409840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam 0.12 mg kg ‐1 and ketamine 2 mg kg ‐1 (MK group)
Number of subjects: 150
Study 37409840 — intervention group
Group type: COMPARATOR
Intervention: All groups (DM, DK, MK)
Number of subjects: 150
Study 33422612 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 Gy SDRT
Number of subjects: 117
Study 33422612 — intervention group
Group type: COMPARATOR
Intervention: 3 × 9 Gy SBRT
Number of subjects: 117
Study 32791411 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% Composted Rice Straw (CRS)
Number of subjects: 0
Study 32791411 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Composted Rice Straw (CRS)
Number of subjects: 0
Study 32791411 — intervention group
Group type: COMPARATOR
Intervention: Control (CK) - 50% peat with 50% perlite
Number of subjects: 0
Study 36163930 — intervention group
Group type: EXPERIMENTAL
Intervention: Asciminib 80mg QD
Number of subjects: 0
Study 36163930 — intervention group
Group type: EXPERIMENTAL
Intervention: Asciminib 40mg BID
Number of subjects: 0
Study 36163930 — intervention group
Group type: EXPERIMENTAL
Intervention: Asciminib 200mg BID
Number of subjects: 0
Study 34137308 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based prenatal exercise program
Number of subjects: 21
Study 32285126 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cedazuridine/decitabine (100 mg/35 mg)
Number of subjects: 80